All 2015 SS presentations
View another way?![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4266-Paganetti.jpg)
SU-A-THEATER Chapter 1: History
HistoryPresented by Harald Paganetti, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 4.5 (higher is better), with 2 responding
VLID: 4266
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4268-Zietman.jpg)
SU-B-THEATER Chapter 2: Clinical Perspective
Clinical PerspectivePresented by Anthony Zietman , MGH, Boston
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4268
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
SU-B-THEATER Chapter 2: Clinical Perspective Q & A
Clinical Perspective Q & APresented by Anthony Zietman , MGH, Boston
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4269
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4270-Palmans.jpg)
SU-C-THEATER Chapter 3: Interaction: Basic
Interaction: BasicPresented by Hugo Palmans, PhD, National Physical Laboratory
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4270
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4272-Das.jpg)
SU-D-THEATER Chapter 4: Interaction: Clinical
Interaction: ClinicalPresented by Indra Das, PhD, Indiana University- School of Medicine
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4272
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4275-Paganetti.jpg)
SU-E-THEATER Chapter 5: Radiobiology
RadiobiologyPresented by Harald Paganetti, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4275
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
SU-E-THEATER Chapter 5: Radiobiology Q & A
Radiobiology Q & APresented by Harald Paganetti, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4274
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4276-Schippers.jpg)
SU-F-THEATER Chapter 6:Production and Delivery
Production and Delivery Part 1Presented by J. Marco Schippers , Kernfysisch Versneller Instituut
This presentation has an average satisfaction 5.0 (higher is better), with 2 responding
VLID: 4276
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4276-Schippers.jpg)
SU-F-THEATER Chapter 6:Production and Delivery
Production and Delivery Part 2Presented by J. Marco Schippers , Kernfysisch Versneller Instituut
This presentation has an average satisfaction 5.0 (higher is better), with 3 responding
VLID: 4277
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4278-Langen.jpg)
SU-G-THEATER Chapter 7: Proton Specific Imaging
Proton Specific ImagingPresented by Katja Langen, PhD, University of Maryland School of Medicine
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 4278
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4278-Langen.jpg)
SU-G-THEATER Chapter 7: Proton Specific Imaging
Proton Specific ImagingPresented by Reinhard Schulte, DM, Loma Linda University
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 4278
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
SU-G-THEATER Chapter 7: Proton Specific Imaging Q & A
Proton Specific Imaging Q & APresented by Reinhard Schulte, DM, Loma Linda University
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4280
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4281-Mazal.jpg)
MO-A-THEATER Chapter 8: Field Shaping; Scattering
Field Shaping; ScatteringPresented by Alejandro Mazal , Curie, Paris
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4281
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4283-Zhu.jpg)
MO-B-THEATER Chapter 9: Field Shaping; Scanning
Field Shaping; ScanningPresented by X. Ronald Zhu, PhD, UT MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4283
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4287-Vatnitsky.jpg)
MO-D-THEATER Chapter 11: Detector
Detector SystemsPresented by Hugo Palmans, National Physical Laboratory
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4287
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4290-Palmans.jpg)
MO-E-THEATER Chapter 12: Dosimetry and Calibration
Dosimetry and CalibrationPresented by Hugo Palmans, PhD, National Physical Laboratory
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4290
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4291-Farr.jpg)
MO-F-THEATER Chapter 13: Acceptance
Acceptance TestingPresented by Jonathan Farr, DSc, St. Jude Children's Research Hospital
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4291
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4292-Kruse.jpg)
MO-F-THEATER Chapter 13: Acceptance
Proton System Acceptance Testing Part 2Presented by Jon Kruse, PhD, Mayo Clinic
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4292
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4294-Arjomandy.jpg)
MO-G-THEATER Chapter 15 - 16: QA
Quality AssurancePresented by Bijan Arjomandy, PhD, McLaren Cancer Institute
This presentation has an average satisfaction 2.7 (higher is better), with 3 responding
VLID: 4294
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4296-Dong.jpg)
TU-A-THEATER Chapter 14: Commissioning
Clinical Commissioning of Proton BeamPresented by Lei Dong, PhD, Scripps Proton Therapy Center
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4296
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4298-Engelsman.jpg)
TU-B-THEATER Chapter 17: Clinical Workflow
Proton Therapy WorkflowPresented by Martijn Engelsman, PhD, Paul Scherrer Institute
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4298
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4300-Mohan.jpg)
TU-C-THEATER Chapter 19: Dose Calculation; Analytical
Dose Calculations for Proton Beam Therapy - Semi-empirical Analytical MethodsPresented by Radhe Mohan, PhD, UT MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4300
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4302-Paganetti.jpg)
TU-D-THEATER Chapter 20: Dose Calculation; Monte Carlo
Dose Calculations for Proton Beam Therapy -Monte CarloPresented by Harald Paganetti, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4302
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4307-Mohan.jpg)
WE-A-THEATER Chapter 21: Uncertainity
Uncertainities in Proton TherapyPresented by Radhe Mohan, PhD, UT MD Anderson Cancer Center
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4307
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4309-Bortfeld.jpg)
WE-B-THEATER Chapter 22: Optimization
Treatment Plan Optimization in Proton TherapyPresented by Thomas Bortfeld, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4309
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
WE-B-THEATER Chapter 22: Optimization Q & A
Optimization Q & APresented by Thomas Bortfeld, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4310
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4311-Dong.jpg)
WE-C-THEATER Chapter 23: Treatment Planning for SFUD
Treatment Planning for SFUDPresented by Lei Dong, PhD, Scripps Proton Therapy Center
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4311
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4311-Dong.jpg)
WE-C-THEATER Chapter 23: Treatment Planning for SFUD
Treatment Planning for SFUDPresented by X. Ronald Zhu, PhD, UT MD Anderson Cancer Center
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4311
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4315-Lomax.jpg)
WE-D-THEATER Chapter 24: Treatment Planning for IMPT
Treatment Planning for Pencil Beam ScanningPresented by Anthony Lomax , Paul Scherrer Institute
This presentation has an average satisfaction 5.0 (higher is better), with 2 responding
VLID: 4315
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4316-Kruse.jpg)
WE-E-THEATER Chapter 18: Immobilization
Immobilization and SimulationPresented by Jon Kruse, PhD, Mayo Clinic
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4316
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4318-Knopf.jpg)
WE-F-THEATER Chapter 25: Motion Management
Motion / Motion Mitigation Part 1Presented by Antje-Christin Knopf, MSc, University of Heidelberg
This presentation has an average satisfaction 4.7 (higher is better), with 3 responding
VLID: 4318
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4319-Mori.jpg)
WE-F-THEATER Chapter 25: Motion Management
Motion ManagementPresented by Shinichiro Mori, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 5.0 (higher is better), with 1 responding
VLID: 4319
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4321-Zhu.jpg)
TH-A-THEATER Chapter 26: MU Calculation
MU CalculationPresented by Timothy Zhu, PhD, Univ Pennsylvania
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4321
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
TH-A-THEATER Chapter 26: MU Calculation Q & A
MU Calculation Q & APresented by Timothy Zhu, PhD, Univ Pennsylvania
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4322
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4323-Winey.jpg)
TH-B-THEATER Chapter 27: SRS; Small Field
Small Field Dosimetry, SRS and EyesPresented by Brian Winey, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 4.0 (higher is better), with 1 responding
VLID: 4323
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
TH-B-THEATER Chapter 27: SRS; Small Field Q & A
SRS; Small Field Q & APresented by Brian Winey, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4324
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4325-Sahoo.jpg)
TH-C-THEATER Chapter 28: In vivo Dosimetry
In vivo Dosimetry for Proton TherapyPresented by Narayan Sahoo, PhD, MD Anderson Cancer Center
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4325
![](//s3.amazonaws.com/AAPM/vl/2015/SS/2015SSQA.jpg)
TH-C-THEATER Chapter 28: In vivo Dosimetry Q & A
In vivo Dosimetry Q & APresented by Harald Paganetti, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4326
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4328-Das.jpg)
TH-D-THEATER Summary & Outlook
Summary & OutlookPresented by Harald Paganetti, PhD, Massachusetts General Hospital
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4328
![](//s3.amazonaws.com/AAPM/vl/2015/SS/0-4328-Das.jpg)
TH-D-THEATER Summary & Outlook
Summary & OutlookPresented by Indra Das, PhD, Indiana University- School of Medicine
This presentation has an average satisfaction 0.0 (higher is better), with 0 responding
VLID: 4328